Dow Inc.
Submit Your Information
If you suffered a loss on your Dow Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.
Background
On June 23, 2025, BMO Capital downgraded its recommendation on Dow from “Market Perform” to “Underperform” and cut its price target on the Company’s stock citing sustained weakness across key end markets and mounting pressure on the Company’s dividend.
On this news, Dow’s stock price fell $0.89, or 3.2%, to close at $26.87 per share on June 23, 2025, thereby injuring investors.
Then, on July 24, 2024, Dow released its second quarter 2025 financial results, reporting a non-GAAP loss per share of $0.42 and net sales of $10.1 billion, missing consensus estimates “reflecting declines in all operating segments.” The Company also revealed that it was cutting its dividend in half, from $0.70 per share to only $0.35 per share, citing the need for “financial flexibility amidst a persistently challenging macroeconomic environment.”
On this news, Dow’s stock price fell $5.30, or 17.5%, to close at $25.07 per share on July 24, 2025, thereby injuring investors further.
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Dow’s ability to mitigate macroeconomic and tariff-related headwinds, as well as to maintain the financial flexibility needed to support its lucrative dividend, was overstated; (2) the true scope and severity of the foregoing headwinds’ negative impacts on Dow’s business and financial condition was understated, particularly with respect to competitive and pricing pressures, softening global sales and demand for the Company’s products, and an oversupply of products in the Company’s global markets; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Submit Your Information